Darolutamide (Nubeqa, BAY1841788): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
0
US states with sites
2
Countries
Phase breakdown
Phase 4 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Non-metastatic Castration-resistant Prostate Cancer | 2 |
| Prostate cancer | 2 |
| Metastatic Hormone-sensitive Prostate Cancer | 1 |
Recruiting trials involving Darolutamide (Nubeqa, BAY1841788)
- A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
- An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Common questions
How many recruiting trials involve Darolutamide (Nubeqa, BAY1841788)?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.